186 related articles for article (PubMed ID: 28101144)
21. The clinical and histopathological features of idiopathic inflammatory myopathies with asymmetric muscle involvement.
Liu M; Hou Y; Dai T; Lv J; Li W; Zhao Y; Fang Q; Yan C
J Clin Neurosci; 2019 Jul; 65():46-53. PubMed ID: 31060889
[TBL] [Abstract][Full Text] [Related]
22. Systemic sclerosis-like histopathological features in the myocardium of uPAR-deficient mice.
Manetti M; Rosa I; Fazi M; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2016 Feb; 75(2):474-8. PubMed ID: 26269399
[TBL] [Abstract][Full Text] [Related]
23. Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis.
Ellezam B; Leclair V; Troyanov Y; Bersali I; Giannini M; Hoa S; Bourré-Tessier J; Nadon V; Drouin J; Karamchandani J; O'Ferrall E; Lannes B; Satoh M; Fritzler MJ; Senécal JL; Hudson M; Meyer A; Landon-Cardinal O
Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12840. PubMed ID: 35894636
[TBL] [Abstract][Full Text] [Related]
24. Clinical and laboratory features of scleroderma patients developing skeletal myopathy.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
Clin Rheumatol; 2005 Apr; 24(2):99-102. PubMed ID: 15322944
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis.
Contini P; Negrini S; Murdaca G; Borro M; Puppo F
Clin Exp Immunol; 2018 Aug; 193(2):152-159. PubMed ID: 29660112
[TBL] [Abstract][Full Text] [Related]
26. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
[TBL] [Abstract][Full Text] [Related]
27. Angiographic characteristics of vasculopathy in patients with idiopathic inflammatory myopathies and systemic sclerosis.
Yeo J; Park EA; Lee EB; Park JK
Sci Rep; 2022 May; 12(1):9051. PubMed ID: 35641535
[TBL] [Abstract][Full Text] [Related]
28. Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.
Michalska-Jakubus M; Cutolo M; Smith V; Krasowska D
Microvasc Res; 2019 Sep; 125():103881. PubMed ID: 31075243
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis.
Maurer B; Distler A; Suliman YA; Gay RE; Michel BA; Gay S; Distler JH; Distler O
Ann Rheum Dis; 2014 Oct; 73(10):1880-7. PubMed ID: 23918036
[TBL] [Abstract][Full Text] [Related]
30. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma.
Magro CM; Nuovo G; Ferri C; Crowson AN; Giuggioli D; Sebastiani M
J Cutan Pathol; 2004 Jan; 31(1):43-50. PubMed ID: 14675284
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical differentiation of inflammatory myopathies.
Panicker JB; Chacko G; Patil AK; Alexander M; Muliyil J
Neurol India; 2011; 59(4):513-20. PubMed ID: 21891925
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of angiogenic homeostasis in systemic sclerosis.
Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
[TBL] [Abstract][Full Text] [Related]
33. Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients.
Manetti M; Neumann E; Milia AF; Tarner IH; Bechi P; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
Arthritis Rheum; 2007 Oct; 56(10):3442-7. PubMed ID: 17907149
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic measures for patients with systemic sclerosis-associated myopathy.
Baumberger R; Jordan S; Distler O; Baschung Pfister P; Maurer B
Clin Exp Rheumatol; 2021; 39 Suppl 131(4):85-93. PubMed ID: 34323680
[TBL] [Abstract][Full Text] [Related]
35. Polymyositis and dermatomyositis - challenges in diagnosis and management.
Yang SH; Chang C; Lian ZX
J Transl Autoimmun; 2019 Dec; 2():100018. PubMed ID: 32743506
[TBL] [Abstract][Full Text] [Related]
36. Expression of Inflammatory Markers in the Muscles of Patients with Idiopathic Inflammatory Myopathy According to the Presence of Interstitial Lung Disease.
Lee JS; Ghang B; Choi W; Hong S; Kim YG; Lee CK; Nam SJ; Yoo B
J Clin Med; 2022 May; 11(11):. PubMed ID: 35683408
[TBL] [Abstract][Full Text] [Related]
37. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
[TBL] [Abstract][Full Text] [Related]
38. Elevated vascular endothelial growth factor in systemic sclerosis.
Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
[TBL] [Abstract][Full Text] [Related]
39. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of additional histopathological fascia examination in idiopathic inflammatory myopathies.
Lim J; Eftimov F; Raaphorst J; Aronica E; van der Kooi AJ
Eur J Neurol; 2019 Dec; 26(12):1494-1496. PubMed ID: 31220379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
